05B4 McKenzie, Steven E. - Jefferson Medical College - Thomas Jefferson University
sem101

Steven E. McKenzie, MD, PhD

Contact Dr. McKenzie

1015 Walnut Street
Suite 409
Philadelphia, PA 19107

(215) 955-3900
(215) 923-3836 fax

Most Recent Peer-reviewed Publications

  1. Monocytes in HIT: An evolving story
  2. CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
  3. Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa)
  4. PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
  5. Amelioration of murine immune thrombocytopenia by CD44 antibodies: A potential therapy for ITP?
  6. Dominant expression of the inhibitory FcγRIIB prevents antigen presentation by murine plasmacytoid dendritic cells
  7. The clot thickens (or not)
  8. Thrombopoietin following transfusion of platelets in preterm neonates
  9. The yin and yang of Fcγ receptors in ITP
  10. Heparin-induced thrombocytopenia: An autoimmune disorder regulated through dynamic autoantigen assembly/disassembly
  11. Cholesterol enrichment of human monocyte/macrophages induces surface exposure of phosphatidylserine and the release of biologically-active tissue factor-positive microvesicles
  12. Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model
  13. Platelet FcγRIIA binds and internalizes IgG-containing complexes
  14. Development of spontaneous multisystem autoimmune disease and hypersensitivity to antibody-induced inflammation in Fcγ receptor IIa-transgenic mice
  15. PF4/heparin complexes are T cell-dependent antigens
  16. A novel human CD32 mAb blocks experimental immune haemolytic anaemia in FcγRIIA transgenic mice
  17. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia
  18. Heparin-induced thrombocytopenia and other immune thrombocytopenias: Lessons from mouse models
  19. Short-Term Use of Umbilical Artery Catheters May Not Be Associated with Increased Risk for Thrombosis
  20. Mechanisms of Action of Therapeutics in Idiopathic Thrombocytopenic Purpura
0